Example: Heart Attack

Search clinical trials for: Tafenoquine

Total 19 results

NCT04411836

Recruiting

Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine

Conditions: Vivax Malaria, Plasmodium Vivax, Malaria, Vivax, Malaria Relapse
NCT04609098

Completed

Single Low Dose Tafenoquine to Reduce P. Falciparum Transmission in Mali (NECTAR2)

Conditions: Malaria, Falciparum
NCT04533347

Recruiting

Tafenoquine in Patients With Mild to Moderate COVID-19

Conditions: COVID 19 Disease
NCT04704999

Not yet recruiting

Southeast Asia Dose Optimization of Tafenoquine

Conditions: Plasmodium Vivax Malaria
NCT02563496

Completed

A Pharmacokinetics, Safety and Efficacy Study of Tafenoquine (TQ) in Pediatric Subjects With Plasmodium Vivax (P. Vivax) Malaria

Conditions: Malaria, Vivax
NCT02802501

Completed

Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria

Conditions: Malaria, Vivax
NCT03320174

Unknown status

Long-Term Safety Study of Tafenoquine

Conditions: Healthy Volunteers
NCT02491606

Completed

Evaluation of Weekly Tafenoquine

Conditions: Malaria
NCT02488902

Completed

A Randomized, Double-blind, Placebo-controlled Evaluation of Increasing Doses of Weekly Tafenoquine for Chemosuppression of Plasmodium Falciparum

Conditions: Malaria
NCT02216123

Completed

Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria

Conditions: Malaria, Vivax
NCT01376167

Completed

Ph 2B/3 Tafenoquine (TFQ) Study in Prevention of Vivax Relapse

Conditions: Malaria, Vivax
NCT02658435

Completed

Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)

Conditions: Malaria, Vivax
NCT01290601

Terminated

Study to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium Vivax in Adults

Conditions: Malaria, Plasmodium Vivax
NCT02184637

Completed

A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine Tetraphosphate

Conditions: Malaria, Vivax
NCT00871156

Completed

Tafenoquine/Chloroquine DDI Study

Conditions: Malaria
NCT01928914

Completed

Tafenoquine Thorough QTc Study in Healthy Subjects

Conditions: Malaria, Vivax
NCT01205178

Completed

G6PD (Glucose-6-phosphate Dehydrogenase) Study to Evaluate Hemolysis Potential of TFQ (Tafenoquine)

Conditions: Malaria
NCT02488980

Completed

An Evaluation of Weekly Tafenoquine

Conditions: Falciparum Parasitaemia
NCT02751294

Completed

A Study to Assess the Effects of Dissolution Profile on the Pharmacokinetics of Single Oral Doses of Tafenoquine Tablets and Tafenoquine Stable Isotope Labelled Solution

Conditions: Malaria, Vivax